Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Forecasting the global demand for HIV monitoring and diagnostic tests: A 2016-2021 analysis.

Habiyambere V, Dongmo Nguimfack B, Vojnov L, Ford N, Stover J, Hasek L, Maggiore P, Low-Beer D, Pérez Gonzàlez M, Edgil D, Williams J, Kuritsky J, Hargreaves S, NeSmith T.

PLoS One. 2018 Sep 19;13(9):e0201341. doi: 10.1371/journal.pone.0201341. eCollection 2018.

3.

The Critical Role of Supply Chains in Preventing Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Settings.

Minior T, Douglas M, Edgil D, Srivastava M, Crowley J, Firth J, Lapidos-Salaiz I, Williams J, Lee L.

J Infect Dis. 2017 Dec 1;216(suppl_9):S812-S815. doi: 10.1093/infdis/jix403.

4.

Next-Generation Human Immunodeficiency Virus Sequencing for Patient Management and Drug Resistance Surveillance.

Noguera-Julian M, Edgil D, Harrigan PR, Sandstrom P, Godfrey C, Paredes R.

J Infect Dis. 2017 Dec 1;216(suppl_9):S829-S833. doi: 10.1093/infdis/jix397.

5.

Progress with Scale-Up of HIV Viral Load Monitoring - Seven Sub-Saharan African Countries, January 2015-June 2016.

Lecher S, Williams J, Fonjungo PN, Kim AA, Ellenberger D, Zhang G, Toure CA, Agolory S, Appiah-Pippim G, Beard S, Borget MY, Carmona S, Chipungu G, Diallo K, Downer M, Edgil D, Haberman H, Hurlston M, Jadzak S, Kiyaga C, MacLeod W, Makumb B, Muttai H, Mwangi C, Mwangi JW, Mwasekaga M, Naluguza M, Ng'Ang'A LW, Nguyen S, Sawadogo S, Sleeman K, Stevens W, Kuritsky J, Hader S, Nkengasong J.

MMWR Morb Mortal Wkly Rep. 2016 Dec 2;65(47):1332-1335. doi: 10.15585/mmwr.mm6547a2.

6.

Progress in Harmonizing Tiered HIV Laboratory Systems: Challenges and Opportunities in 8 African Countries.

Williams J, Umaru F, Edgil D, Kuritsky J.

Glob Health Sci Pract. 2016 Sep 29;4(3):467-80. doi: 10.9745/GHSP-D-16-00004. Print 2016 Sep 28.

7.

Optimising the laboratory supply chain: The key to effective laboratory services.

Edgil D, Williams J, Smith P, Kuritsky J.

Afr J Lab Med. 2014 Sep 5;3(1):101. doi: 10.4102/ajlm.v3i1.101. eCollection 2014.

8.

Cost analysis of integrating the PrePex medical device into a voluntary medical male circumcision program in Zimbabwe.

Njeuhmeli E, Kripke K, Hatzold K, Reed J, Edgil D, Jaramillo J, Castor D, Forsythe S, Xaba S, Mugurungi O.

PLoS One. 2014 May 6;9(5):e82533. doi: 10.1371/journal.pone.0082533. eCollection 2014.

9.

Voluntary medical male circumcision: logistics, commodities, and waste management requirements for scale-up of services.

Edgil D, Stankard P, Forsythe S, Rech D, Chrouser K, Adamu T, Sakallah S, Thomas AG, Albertini J, Stanton D, Dickson KE, Njeuhmeli E.

PLoS Med. 2011 Nov;8(11):e1001128. doi: 10.1371/journal.pmed.1001128. Epub 2011 Nov 29.

10.

Evaluating outcomes of the President's Emergency Plan for AIDS Relief in Africa.

Johnson PD, Heaton LM, Way PO, Fowler TB, Edgil DM.

Ann Intern Med. 2010 Jan 19;152(2):132; author reply 132-3. doi: 10.7326/0003-4819-152-2-201001190-00020. No abstract available.

PMID:
20083837
11.

Molecular biology of flaviviruses.

Harris E, Holden KL, Edgil D, Polacek C, Clyde K.

Novartis Found Symp. 2006;277:23-39; discussion 40, 71-3, 251-3. Review.

PMID:
17319152
12.
13.

End-to-end communication in the modulation of translation by mammalian RNA viruses.

Edgil D, Harris E.

Virus Res. 2006 Jul;119(1):43-51. Epub 2005 Nov 22. Review.

PMID:
16307817
14.

Translation efficiency determines differences in cellular infection among dengue virus type 2 strains.

Edgil D, Diamond MS, Holden KL, Paranjape SM, Harris E.

Virology. 2003 Dec 20;317(2):275-90.

15.

Complete nucleotide sequence analysis of a Brazilian dengue virus type 2 strain.

dos Santos FB, Miagostovich MP, Nogueira RM, Edgil D, Schatzmayr HG, Riley LW, Harris E.

Mem Inst Oswaldo Cruz. 2002 Oct;97(7):991-5.

16.

Infection of human cells by dengue virus is modulated by different cell types and viral strains.

Diamond MS, Edgil D, Roberts TG, Lu B, Harris E.

J Virol. 2000 Sep;74(17):7814-23.

17.

Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons.

Diamond MS, Roberts TG, Edgil D, Lu B, Ernst J, Harris E.

J Virol. 2000 Jun;74(11):4957-66.

18.

Supplemental Content

Support Center